Search Results 1-10 of 15321 for Proto-oncogene
JACKSONVILLE, Fla. — Researchers at Mayo Clinic have identified a genetic promoter of cancer that drives a major form of lung cancer.
The Department of Cancer Biology at Mayo Clinic is studying oncogenic gene dysregulation and carcinogenesis, including the cancer signaling process.
“We discovered that in these particular cases, the cancer exhibited a MET oncogene amplification, which creates a hostile environment for immunotherapy,” says ...
10 issue of Cancer Cell the discovery of two oncogenes that work together to sustain a population of cells in lung squamous cell carcinoma, which may be ...
Interpret technology — immunostains, RET proto-oncogene, DNA ploidy, reverse transcription-polymerase chain reaction (RT-PCR), gene profiling and implications ...
... proto-oncogene 1. Gastroenterology. 2023 Jul; 165 (1):228-43.e2; Ilyas SI, Affo S, Goyal L, Lamarca A, Sapisochin G, Yang JD, Gores GJ. Cholangiocarcinoma ...
Bidirectional sequence analysis was performed to test for the presence of a mutation in exons 10, 11, 13, 14, 15 and 16 of the RET proto-oncogene and was ...
Natalia Genere, M.D., and Robert D. Tiegs, M.D., discuss the care plan for a woman who presented with multiple, nontraumatic fractures discovered during a ...
This oncogene creates an immunosuppressive tumor microenvironment that confers resistance to immune checkpoint inhibitor therapy, a promising treatment modality ...
That's according to new Mayo Clinic research. The findings, published this month in Oncogene, indicate that increasing the expression of the PD-L1 protein in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.